Introduction {#S1}
============

*Escherichia coli* is a versatile Gram-negative bacterium whose genome is shaped by lateral gene transfer. The plasticity of *E. coli* genomes allows for some strains to exist as gastrointestinal tract commensals, while the acquisition of different combinations of virulence-associated genes (VAGs) has generated clades that cause a diverse range of intestinal and extraintestinal illnesses ([@B89]). Pathogenic *E. coli* that induce intestinal disease are known as diarrheagenic *E. coli* (DEC) and are classified into pathotypes according to specific virulence factors and ensuing clinical manifestations ([@B43]).

Enterohemorrhagic *E. coli* (EHEC) and enteropathogenic *E. coli* (EPEC) are DEC pathotypes that share a common mechanism of pathogenesis defined in part by the carriage of a chromosomally located pathogenicity island (PAI) termed the locus of enterocyte effacement (LEE). The LEE enables EPEC and EHEC to adhere intimately to intestinal epithelial cells and cause attaching and effacing (A/E) lesions leading to diarrheal illness ([@B54]). The genes located within the LEE are sufficient for A/E lesion formation, as transferring LEE to commensal *E. coli* confers A/E lesion activity ([@B70]). In addition to the LEE, EHEC and EPEC possess various non-LEE (*nle*)-encoded effector genes. *nle* genes are frequently carried on prophage elements and contribute to virulence by interfering with host signaling pathways, apoptosis and phagocytosis ([@B100]) as well as disrupting host cell cytoskeleton and tight junctions ([@B43]). However, EHEC differ from EPEC in that they possess phage-associated Shiga toxins (*stx*), which contribute to the hemorrhagic colitis and hemolytic uremic syndrome (HUS) associated with EHEC infections ([@B69]). EHEC also fall under the category of Shiga toxin-producing *E. coli* (STEC); however, STEC encompass both LEE-positive (typical EHEC) and LEE-negative (atypical EHEC) *E. coli.*

EPEC are further classified into typical EPEC (tEPEC) and atypical EPEC (aEPEC) by the presence, in the former, of the EPEC adherence factor plasmid (pEAF) encoding bundle-forming pili ([@B43]). tEPEC and aEPEC also differ in terms of serogroups, reservoirs and virulence factors. tEPEC generally belong to the twelve classical EPEC serogroups recognized by the World Health Organization (O26, O55, O111, O114, O119, O126, O127, O128, O142, O158) ([@B101]). Humans are their principal reservoir ([@B91]), and their virulence factors are mainly encoded by LEE and pEAF ([@B2]). Conversely, aEPEC strains belong to more than 4200 different serotypes ([@B43]), and include tEPEC and EHEC that have lost pEAF and *stx* genes, respectively ([@B3]; [@B15]). aEPEC infect both human and animal hosts ([@B48]) and are also more heterogeneous than tEPEC in their virulence factors; frequently carrying genes associated with other DEC pathotypes, including enterohemolysin (*ehxA*) and heat-stable enterotoxin (*astA*) ([@B9]).

aEPEC strains have been associated with persistent diarrhea in both humans ([@B48]) and animals ([@B97]; [@B7]) and in diarrheal outbreaks in Brazil, China, Finland, Japan, and the United States ([@B48]; [@B43]). While recent epidemiological studies have indicated that aEPEC is more prevalent than tEPEC in both industrialized and developing countries ([@B48]), aEPEC pathogenicity remains controversial due to similar isolation rates from both diarrheic and non-diarrheic hosts ([@B43]). Establishing a baseline for which virulence factors may or may not contribute to disease can help elucidate the mechanisms behind aEPEC pathogenicity.

*Escherichia coli* is not only an agent of disease, but also a driving force behind antimicrobial resistance (AMR). In fact, *E. coli* is one of the most significant global concerns in human and animal health sectors, the food industry and in the environment ([@B73]). AMR surveillance programs have indicated that resistance to all the major classes of antibiotics now circulate among *E. coli* strains ([@B77]), including extended-spectrum β-lactams (ESBL), carbapenems, and more recently, plasmid-mediated colistin resistance (*mcr-1*), particularly in food animals from China and Vietnam ([@B63]; [@B49]; [@B23]). The ubiquitous nature of *E. coli* means it constitutes a shared reservoir for AMR across a One Health framework, and concerns have been raised about the possible transmission of AMR *E. coli* between animals and humans through direct contact or via the food chain ([@B78]). As inter- and intraspecies horizontal gene transfer (HGT) and mobile genetic elements (MGE) are considered the prevailing mechanisms that drive AMR ([@B92]; [@B74]), close genomic surveillance of AMR cargo within *E. coli* populations is warranted.

aEPEC from sequence type (ST) 302 (serotype O108:H9) have been isolated from both healthy and diseased hosts, and the environment. They have been isolated from healthy pigs ([@B38]; [@B67]; [@B81]), water tanks in a poultry slaughterhouse ([@B6]) and pork products made for human consumption ([@B64]), and have been associated with diarrheic rabbits ([@B107]), pigs ([@B55]), and humans ([@B36]). Yet to date, no genomic comparisons of *E. coli* ST302 strains, nor a complete ST302 genome, has been published. Here we sequenced and annotated the complete genome of *E. coli* aEPEC strain F2_18C (ST302, O108:H9), isolated from a healthy pig not previously treated with antibiotics on an Australian farm. We performed comparative analyses with other *E. coli* ST302 strains, screening for virulence and AMR cargo, and compared F2_18C's three plasmids -- an HI2:ST3 plasmid with homology to colistin-resistant plasmids, an FIB plasmid with homology to the EHEC virulence plasmid, and a colRNAI plasmid carrying colicin-10 -- to other plasmids with high sequence identity.

Materials and Methods {#S2}
=====================

Ethics Statement {#S2.SS1}
----------------

NSW Department of Primary Industries did not require the study to be reviewed or approved by an ethics committee as *E. coli* strain F2_18C was isolated from a veterinary sample provided by the farm veterinarian as part of routine diagnostics.

Isolation and Storage of *E. coli* Strain F2_18C {#S2.SS2}
------------------------------------------------

Strain F2_18C was isolated from a commercial-raised, healthy piglet (weaner), not previously treated with antibiotics, on an Australian farm as previously described ([@B81]). The strain was cultured in LB medium, frozen as a glycerol stock (500 μl M9 salts solution, 500 μl 50% v/v glycerol) and stored at −80°C. The strain was again cultured in LB medium before total cellular DNA isolation for sequencing.

DNA Extraction, Whole-Genome Sequencing and Assembly {#S2.SS3}
----------------------------------------------------

For short-read sequencing, DNA was extracted using the ISOLATE II genomic DNA kit (Bioline) and stored at −20°C. Short-read sequencing was performed using an Illumina HiSeq 2500 v4 sequencer in rapid PE150 mode as previously described ([@B81]). For long-read sequencing, DNA was extracted from mid-log phase sub-cultures of strains grown overnight in LB broth using a gentle phenol-chloroform extraction protocol. Long-read sequencing was performed by the Ramaciotti Centre for Genomics using a Pacific Bioscience (PacBio) RSII sequencer with P6-C4 chemistry. Sequence read quality was assessed using FastQC version 0.11^[1](#footnote1){ref-type="fn"}^. A hybrid assembly, using both Illumina and PacBio reads, was produced using Unicycler ([@B99]).

Genome Annotation {#S2.SS4}
-----------------

Automated annotations were generated by RASTtk ([@B18]) and managed using SnapGene v4.1.9. Manual annotations were added using publicly available databases and tools: insertion sequences (IS) were annotated manually using ISfinder ([@B85])^[2](#footnote2){ref-type="fn"}^; genomic islands (GIs) were identified using IslandViewer 4 ([@B13])^[3](#footnote3){ref-type="fn"}^; functional assignments of ORFs were designated using the Comprehensive Genome Analysis service available through Pathosystems Resource Integration Center (PATRIC v3.5.41) ([@B98])^[4](#footnote4){ref-type="fn"}^ and; phage elements were identified using Phage Search Tool Enhanced Release (PHASTER) ([@B8])^[5](#footnote5){ref-type="fn"}^. Sequences for the F2_18C chromosome, pF2_18C_HI2, pF2_18C_FIB, pF2_18C_Col have been deposited to NCBI under the accession numbers [CP043542](CP043542), [CP043545](CP043545), [CP043544](CP043544), and [CP043543](CP043543), respectively, and annotated using the NCBI automated pipeline. Authors' annotations (GenBank files) can be viewed in [Supplementary Data S1](#DS1){ref-type="supplementary-material"}.

Phylogenetic Analysis {#S2.SS5}
---------------------

Maximum-likelihood phylogenetic distances between genomes were analyzed using Phylosift ([@B29]), generated using FastTree2 ([@B79]), and visualized using both FigTree v1.4.2^[6](#footnote6){ref-type="fn"}^ and the Interactive Tree of Life (iTOL v4) ([@B60])^[7](#footnote7){ref-type="fn"}^. SNP-based phylogenetic analysis was performed using Snplord, an automated pipeline that utilizes snippy^[8](#footnote8){ref-type="fn"}^, Gubbins^[9](#footnote9){ref-type="fn"}^, SNP-sites^[10](#footnote10){ref-type="fn"}^, and FastTree 2. Snplord is available at <https://github.com/CJREID/snplord>. The ST302 pangenome was calculated by Roary v3.11.2 ([@B72]).

Genotyping, Serotyping, and Phylogenetic Classification {#S2.SS6}
-------------------------------------------------------

F2_18Cs ST, serogroup and phylogroup were determined *in silico* using MLST 2.0 ([@B59])^[11](#footnote11){ref-type="fn"}^, SerotypeFinder 2.0 ([@B53])^[12](#footnote12){ref-type="fn"}^ and ClermontTyping ([@B25])^[13](#footnote13){ref-type="fn"}^, respectively. To compare VAG, AMR gene and plasmid replicon carriage between F2_18C and other *E. coli* ST302 strains, short-reads of publicly available *E. coli* ST302 strains were first downloaded from Enterobase ([@B5]; downloaded 01/09/18)^[14](#footnote14){ref-type="fn"}^ and then screened using ARIBA read-mapping tool ([@B50]), using the following reference databases: ResFinder ([@B105])^[15](#footnote15){ref-type="fn"}^, CARD ([@B51])^[16](#footnote16){ref-type="fn"}^, VirulenceFinder ([@B52])^[17](#footnote17){ref-type="fn"}^, VFDB ([@B62])^[18](#footnote18){ref-type="fn"}^, and PlasmidFinder ([@B22])^[19](#footnote19){ref-type="fn"}^. ARIBA data was processed using a bespoke script accessible at <https://github.com/maxlcummins/ARIBAlord>.

Plasmid and Pathogenicity Island Comparisons {#S2.SS7}
--------------------------------------------

Plasmids with high sequence identity (\>98%) were found through the PLSDB v2019_06_03 ([@B39])^[20](#footnote20){ref-type="fn"}^ and comparative analyses were achieved using BRIG ([@B4])^[21](#footnote21){ref-type="fn"}^ and Mauve ([@B28])^[22](#footnote22){ref-type="fn"}^. Mauve and Easyfig ([@B88]) were used to compare PAI~*CL*3~ and ETT2 pathogenicity islands.

Phenotypic Resistance Testing {#S2.SS8}
-----------------------------

F2_18C phenotypic resistance was tested using the calibrated dichotomous susceptibility (CDS) test ([@B11]) against the following antibiotics: ampicillin (25 μg), azithromycin (15 μg), cefoxitin (30 μg), ciprofloxacin (2.5 μg), chloramphenicol (30 μg), gentamicin (10 μg), imipenem (10 μg), kanamycin (50 μg), nalidixic acid (30 μg), neomycin (30 μg), streptomycin (25 μg), sulphafurazole (300 μg), tetracycline (10 μg), and trimethoprim (5 μg).

Results {#S3}
=======

General Genomic Features of *E. coli* Strain F2_18C {#S3.SS1}
---------------------------------------------------

*Escherichia coli* strain F2_18C has a circular genome of 5,439,436 bp consisting of 5436 CDS, 158 repeat regions, 91 tRNA and 22 rRNA. Virulence Factor Database (VFDB) identified 114 VAGs, and the Comprehensive Antibiotic Resistance Database (CARD) identified 85 antimicrobial resistance (AMR) genes. The National Database of Antibiotic Resistance Organisms (NDARO) database identified 15 AMR genes ([Figure 1A](#F1){ref-type="fig"}). In terms of functional properties, strain F2_18C has 4753 genes encoding proteins with functional assignments and 683 hypothetical proteins. The three categories in which the most genes are attributed to are metabolism (*n* = 972), energy (*n* = 333), and protein processing (*n* = 265) ([Figure 1B](#F1){ref-type="fig"}).

![General features of strain F2_18C compared to *E. coli* strains Sakai and MG1655. **(A)** Table listing general genomic features. **(B)** Subsystem class gene distributions. Number in brackets represent number of genes assigned to each functional category.](fmicb-10-03098-g001){#F1}

When compared to a highly pathogenic *E. coli* strain (O157:H7 strain Sakai), and a non-pathogenic *E. coli* strain (laboratory strain MG1655), strain F2_18C had fewer VAGs than Sakai (*n* = 141) but more than MG1655 (*n* = 60). However, F2_18C had more AMR genes than both Sakai (77 CARD/1 NDARO) and MG1655 (75 CARD/1 NDARO). An interesting observation regarding differences in functional properties between the three strains was the number of genes associated with mobile elements (prophages, transposable elements and plasmids) -- 165 for F2_18C, 394 for Sakai, and 2 for MG1655. A complete list of F2_18C gene functional assignments (GO assignments, subsystems, and PL/PGfam) and specialty genes (VAGs, transporters, drug targets, and AMR genes) can be viewed in [Supplementary Table S1](#TS1){ref-type="supplementary-material"}.

Phylogenetic Analysis {#S3.SS2}
---------------------

Porcine *E. coli* strain F2_18C was determined to be ST ST302, serotype O108:H9 and phylogroup E or clade I by Achtman 7 MLST, *in silico* serotype prediction and *in silico* Clermont typing, respectively. To determine the genetic relatedness of F2_18C to other *E. coli* ST302 strains and to other *E. coli* strains in general, all publicly available ST302 genomes (*n* = 14), and 67 *E. coli* genomes of varying STs, serotypes, and phylogroups were used to construct a phylogenetic tree ([Figure 2](#F2){ref-type="fig"}; details of analyzed genomes found in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Where known, the ST302 genomes analyzed in this study were from a range of hosts, including pigs, poultry, companion animals and humans, and from broad geographical locations, including Australia, Canada, Kenya, Slovakia, the United Kingdom, and the United States. Tree topology demonstrated consonance between STs, serotypes and phylogroups. The analysis showed that *E. coli* ST302 strains are most closely related to a branch of ST32s (serotype O145:H28, phylogroup D) and that they all belong to the E or cryptic clade 1 phylogroup and carry the H9 antigen. However, three ST302 serogroups were identified -- O182, O45, and O108 -- the latter being the most common (*n* = 11; 73%). Additionally, F2_18C and two O182:H9 strains (29396 and 29563) formed an offshoot branch from the other ST302 strains. An ST302 SNP analysis demonstrated that F2_18C was separated from its closest relative (29396) by 684 SNPs, and its most distant relative (FSIS11706110) by 2139 SNPs. SNP analysis details, including SNP sites and distribution, can be viewed in [Supplementary Data S2](#DS2){ref-type="supplementary-material"}. The ST302 pangenome comprised a total of 10262 genes, with 3558 genes forming the core genome (genes present in 100% of ST302 strains), and 6704 genes forming the accessory genome (shell genome \[15--95% ST302 strains\] = 2587 genes; cloud genome \[\<15% ST302 strains\] = 4117 genes). Pangenome details, including gene absence/presence table and Roary-generated graphs, can be viewed in [Supplementary Table S3](#TS3){ref-type="supplementary-material"}.

![Maximum-likelihood phylogenetic tree showing genetic relatedness of *E. coli* strain F2_18C. Phylosift, FastTree2, FigTree and iTOL were used to generate and visualize a maximum-likelihood phylogenetic tree, rooted on *E. coli* laboratory strain MG1655. A total of 91 *E. coli* strains were used, including all publicly available *E. coli* ST302 strains. The colored bands that form the outer ring relate to each strains ST and the second ring refers to serotype. Icons around the circumference refer to the host or environment from which the strains were isolated. Shading over tip labels indicates phylogroups. F2_18C is shown in bold. ^∗^Indicates an abbreviated strain name: 400654^∗^ = Escherichia_coli_400654-sc-2012-01-13T20:11:31Z-1332520; DTU2016^∗^ = DTU2016\_ 526\_ PRJ1050\_ Eschericha_coli_Isol133.](fmicb-10-03098-g002){#F2}

ST302 Gene Screening {#S3.SS3}
--------------------

All *E. coli* ST302 strains, including strain F2_18C, were screened for acquired antimicrobial resistance genes (ARGs), heavy metal resistance genes, VAGs and plasmid replicons using Ariba. The text below refers to genes presented in [Figure 3](#F3){ref-type="fig"}, which is a selection of significant VAG and ARG, the full list of screened genes can be viewed in [Supplementary Table S4](#TS4){ref-type="supplementary-material"}.

![Heatmap and SNP tree of ST302 virulence factors, antimicrobial resistance and plasmid replicons. Intact genes are represented in solid colors, while partial, fragmented or interrupted genes are less opaque. Partial, fragmented and interrupted genes encompass all non-intact genes. ARGs and heavy metal resistance genes are shown in yellow, VAGs in red, and plasmid replicons in purple. Host and country of origin depicted on the right. F2_18C boxed in blue. Tree branch colors are representative of host -- red = human; yellow = poultry; green = canine; blue = porcine; black = unspecified. ^∗^Indicates an abbreviated strain name: 400654^∗^ = Escherichia_coli_400654-sc-2012-01-13T20:11:31Z-1332520; DTU2016^∗^ = DTU2016_526\_ PRJ1050\_ Eschericha_coli_Isol133. The phylogenetic tree was produced by SNP-based phylogenetic analysis.](fmicb-10-03098-g003){#F3}

### Acquired ARGs and Heavy Metal Resistance Genes {#S3.SS3.SSS1}

In *E. coli* ST302 strains, genes conferring resistance to aminoglycosides, beta-lactams, fluoroquinolones, macrolides, phenicols, sulfonamides, tetracycline and trimethoprim were detected ([Figure 3](#F3){ref-type="fig"}). No genes conferring resistance to extended-spectrum beta-lactams and carbapenems were detected in any *E. coli* ST302 strains. Strain F2_18C had the greatest number of ARGs (11 versus an average of 3), was 1 of 4 strains carrying resistance genes to 3 or more classes of antibiotics, and was 1 of 2 strains with an intact *intI1*, the other belonging to strain 267792, isolated from a human in the United Kingdom. The most common acquired ARGs across *E. coli* ST302 strains were streptomycin resistance genes *strA* and *strB* (*n* = 7; 47%), tetracycline resistance gene *tetA* (*n* = 5; 33%), aminoglycoside resistance gene *aadA1* (*n* = 4; 27%), and sulfonamide resistance gene *sul1* (*n* = 4; 27%). In terms of heavy metal resistance genes, *E. coli* ST302 strains carry intact copper resistance gene *pcoA* (*n* = 2; 13%), silver resistance gene *silA* (*n* = 1; 7%), and tellurite resistance gene *terA* (*n* = 6; 40%).

Strain F2_18C phenotypic resistances and ARGs were congruent. F2_18C was resistant to sulphafurazole (*sul1, sul3*), tetracycline (*tetA*), streptomycin (*strA, strB*), chloramphenicol (*cmlA*), kanamycin and neomycin \[*aph(3')-IIa*\], and trimethoprim (*dfrA12*). F2_18C also possesses two additional aminoglycoside resistance genes *aadA1* and *aadA2*.

### Virulence-Associated Genes {#S3.SS3.SSS2}

All *E. coli* ST302 strains possess the LEE pathogenicity island adhesin gene *eae* (β variant in F2_18C) but lack Shiga toxin genes (*stx*), and bundle-forming pili (BFP) genes, broadly classifying them as aEPEC. Strain F2_18C had the most VAGs of all the O108:H2 serotypes (*n* = 23, versus an average of 14) ([Figure 3](#F3){ref-type="fig"}). However, the two O182:H9 strains, 29563 and 29396, which together with F2_18C, form an offshoot from other *E. coli* ST302 strains ([Figure 1](#F1){ref-type="fig"}), had the highest number of VAGs overall (*n* = 33 each). The additional VAGs seen in these two strains, but not in F2_18C include adhesin *iha*, bacteriocins *cvaA, mchB, mchC, mchF, mcmA, shiD*, aerobactin iron acquisition genes (*iucABCD*, *iutA*), and non-LEE effectors *espL2, nleB1* and *nleE*. Strains F2_18C, 29563 and 29396 were the only *E. coli* ST302 strains to possess EHEC virulence plasmid associated genes *ehxA, etpD* and *katP.*

Regarding adherence, in addition to aforementioned *eae, iha* and *fimH*, two strains, DTU2016 and MODI-EC5617, possess an intact EAEC adhesin encoding gene *air*, and all other strains have at least partial hits to this gene. Most strains also have at least partial *efa1* (EHEC factor for adherence; *n* = 14; 93%) and *fdeC* (factor adherence *E. coli*; *n* = 13; 87%) genes. However, they all lack *paa* (porcine attaching-effacing associated protein) and plasmid-associated *toxB* genes. Regarding iron uptake, all *E. coli* ST302 strains possess *E. coli* heme uptake (*chu*) and enterobactin genes (*ent*, *fep*). Only the aforementioned O182:H9 strains had aerobactin genes, however several strains, including F2_18C, also possess *fecA* (*n* = 6; 40%) and *sitA* (*n* = 10; 67%). *E. coli* ST302 strains carry an array of non-LEE effector genes, the most common being *cif* (cycle inhibiting factor; *n* = 12; 80%), *espL1* (*n* = 12; 80%), and *nleH1* (*n* = 10; 67%), and the least common being *nleD* (*n* = 2; 13%), which F2_18C possesses, and *nleE* (*n* = 2; 13%). In terms of immune evasion and survival, *E. coli* ST302 strains possess *iss* (increases serum survival; *n* = 11; 73%), *traT* (*n* = 15, 100%), and *gtrA* (*n* = 2; 13%). For invasion, ST302 have *ipaH* (*n* = 14; 93%), *tia* (*n* = 2; 13%), and all have at least partial *aslA.* Several *E. coli* ST302 strains have hemolysin toxin genes, and two strains (MOD1-EC1934 and MOD1-EC5507) also possess *astA* (heat-stable enterotoxin 1/EAST-1). As ARIBA gene screening utilizes Illumina short reads only, the F2_18C chromosome was interrogated manually, using BLASTp and VFDB for reference sequeneces, for gene products flagged as not intact (only VAGs absent in laboratory *E. coli* strain MG1655 were searched). The amino acid (a.a) sequence identity of these ORFs compared to pathogenic *E. coli* strains are shown in [Table 1](#T1){ref-type="table"}, and EPEC and/or EHEC VAGs absent in F2_18C are shown in [Table 2](#T2){ref-type="table"}.

###### 

Interrogated F2_18C chromosomal VAGs.

  **Function**                **Gene**      **% a. a sequence identity**   **Compared *E. coli* strain**   **VAG Pathotype**   **ARIBA output**   **Comments**
  --------------------------- ------------- ------------------------------ ------------------------------- ------------------- ------------------ ------------------------------------------------------------------------------------
  Adhesion                    *cgsA-G*      98.55-100                      EC958                           UPEC                Missing            False-negative
                              *eaeH*        61.21                          Sakai                           Multiple            Missing            Split into 2 ORFS, missing N and C termini, 146 kDa in F2_18C vs. 150 kDa in Sakai
                              *aidA-1*      96.63                          Sakai                           Multiple            Missing            False-negative
                              *upaG*        86.76                          Sakai                           Multiple            Missing            False-negative
                              *air*         55.04                          042                             UPEC, EAEC, NMEC    Partial            Missing 117 kDa fragment
  Non-LEE encoded effectors   *tccP*        71.51                          Sakai                           EHEC, EPEC          Fragmented         Missing middle section, 33 kDa in F2_18C vs. 37 kDa in Sakai
                              *efa1*        5.616                          11128                           EHEC, EPEC          Partial            C-terminus only (100% identity), 21 kDa in F2_18C vs. 366 kDa in 11128
                              *espY2*       51.08                          Sakai                           EHEC, EPEC          Missing            Additional C-terminus, 31 kDa in F2_18C vs. 21 kDa in Sakai
                              *espY3*       87.00                          Sakai                           EHEC, EPEC          Interrupted        Split into 2 ORFs
                              *nleC*        24.78                          Sakai                           EHEC, EPEC          Partial            N-terminus only, 11 kDa in F2_18C vs. 37 kDa in Sakai
                              *nleG2-2*     77.49                          Sakai                           EHEC, EPEC          Missing            
                              *nleH1-1*     97.95                          Sakai                           EHEC, EPEC          Interrupted        False-negative
                              *nleH1-2*     49.51                          Sakai                           EHEC, EPEC          Interrupted        Missing N and C termini, 21 kDa in F2_18C vs. 34 kDa in Sakai
  Invasion                    *ibeB*        99.13                          Sakai                           Multiple            Missing            False-negative
                              *ibeC*        72.96                          11368                           Multiple            Missing            False-negative
  Toxin                       *clyA/hlyE*   98.69                          Sakai                           Multiple            Missing            False-negative

###### 

EPEC/EHEC VAGs absent in F2_18C.

  **Function**                                                     **VAG present in some EPEC and/or EHEC strains**
  ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Adhesion                                                         *paa, lpfA, toxB, perA*
  Non-LEE encoded effectors                                        *espJ, espK, espL2, espM1-2, espN, espO, espW, espX6-X7, espY1, espY5, nleB1, nleB2-2, nleE, nleG, nleG2-G8*
  Serine Protease Autotransporters of Enterobacteriaceae (SPATE)   *ehaC, espP, pet, sepA, tsh*
  Secretion                                                        ACE T6SS (*aec* genes)
  Toxins                                                           *astA, sen, stx*

### Plasmid Replicons {#S3.SS3.SSS3}

All *E. coli* ST302 strains were identified as possessing at least two plasmid replicons ([Figure 3](#F3){ref-type="fig"}). Various Col plasmids were identified in 9 strains (60%), FIA in 1 strain, FIB in 7 strains (47%), various FII in 14 strains (93%), HI2 in 2 strains (13%), I1 in 4 (27%), I2 in a single strain, Y in 2 strains (13%) and pO111 in 6 (40%). FII, FIB, HI2 and ColRNAI replicons were identified in F2_18C.

F2_18C Mobile Genetic Elements {#S3.SS4}
------------------------------

### F2_18C Chromosomal MGEs {#S3.SS4.SSS1}

The F2_18C chromosome has 52 intact ISs with IS*1203* (and IS*1203*-like) occurring the most frequently (*n* = 23), followed by a novel IS with some homology to IS*Kpn28* (*n* = 7, 85% sequence identity to IS*Kpn28*), and IS*4* (*n* = 6). Several IS*1203*s disrupt ORFs, including a DNA protecting protein DprA (458183.459396), *N*-acetylgalactosamine-6-phosphate deacetylase (600929.602142), [D]{.smallcaps}-glucarate transporter (1032798.1034011), lipoprotein YnfC (2369004.2370217) and invasion plasmid antigen (2788262.2789475).

When comparing F2_18C with other ST302 strains, MGEs contribute significantly to chromosomal variations ([Figure 4](#F4){ref-type="fig"}). PHASTER identified four intact prophages, three questionable, and six incomplete prophages within the F2_18C chromosome and these carry several VAGs such as non-LEE effector genes (*nleB2-1*, *nleC*-like, *nleF*, *nleD*, partial *nleG*, *nleH*, *nleH-1*), Tir-cytoskeleton coupling protein *tccP2*, increased serum survival *iss*, cycle inhibiting factor *cif*, and Z2121 (pathogenicity island OI-57 protein). *nleA nleF* and *nleH1-1* are marker genes for pathogenicity island OI-71, however in F2_18C they are carried by various phage elements ([Figure 4](#F4){ref-type="fig"}). The phage elements also carry several heavy metal-associated genes such as *sitABCD* (iron transport), *fecABCDR* (iron transport), *tonB* and *fiu* (iron transport), *zinT* (zinc binding), *zntB* (cadmium, zinc, and copper resistance), *copR* (copper resistance), and *trkG* (potassium uptake). PHASTER output is provided in [Supplementary Data S3](#DS3){ref-type="supplementary-material"}.

![BRIG diagram of MGE distribution in the F2_18C chromosome compared to other ST302 strains. Along the periphery, intact prophages are shown in red, incomplete prophages in navy and GIs in green. Some notable genes present in these regions are labeled accordingly. ^∗^Indicates an abbreviated strain name: 400654^∗^ = Escherichia_coli_400654-sc-2012-01-13T20:11:31Z-1332520; DTU2016^∗^ = DTU2016_526\_ PRJ1050\_ Escherichia \_coli_Isol133.](fmicb-10-03098-g004){#F4}

IslandViewer4 was used to identify genomic islands (GIs). The GIs predicted by at least two algorithms are depicted in [Figure 4](#F4){ref-type="fig"}, and a full list can be viewed in [Supplementary Table S5](#TS5){ref-type="supplementary-material"}. Notably, F2_18C possesses an intact LEE pathogenicity island, with β1-eae and β-tir, and LEE-encoded T3SS effectors. The PAI is attached at tRNA-Phe. F2_18C also possesses a near-intact *E. coli* type 3 secretion system island 2 (ETT2) ([Figure 5A](#F5){ref-type="fig"}). This island in F2_18C has fewer pseudogenes than in *E. coli* strain Sakai (3 vs. 5) however *epaS* is split into two ORFs, EivC is truncated at the C-terminus by 13.7 kDa (120 amino acids), and an IS*1F* insertion which interrupts *eivG*, removing 18 kDa (163 amino acids) off the product's N-terminus. Furthermore, F2_18C possesses a near-complete PAI~*CL*3~ pathogenicity island containing adhesin, hemolysin and pagC-like genes. When compared to the original PAI~*CL*3~ found in *E. coli* O113:H21 (STEC) strain CL3, F2_18C PAI~*CL*3~ is smaller by 3629 bp (23668 bp vs. 27297 bp). This is largely due to missing the right-side boundary genes S15 and Z1644, and only possessing a fragment of Z1643 ([Figure 5B](#F5){ref-type="fig"}). Other notable differences are as follows: the *Yersinia pestis* ShlA/HecA/FhaA family adhesin (S3/S4 in CL3) appears to be split into 3 ORFs in F2_18C and is larger by 277 amino acids than in strain CL3; the transposase-like factor is truncated at the N-terminus and is smaller by 6.8 kDa (58 amino acids) than the equivalent S6 in CL3.; integrase (S7 in CL3) is extended at the N-terminus making it 18.7 kDa (160 amino acids) larger than S7 and; type VI secretion related protein ImpA does not appear truncated at the N- or C-terminus as it does in CL3, making it 25.7 kDa (227 amino acids) larger than S14. Immediately downstream to the F2_18C PAI~*CL*3~ right-side boundary is a phage T7 exclusion protein, NTPase KAP ([Figure 5B](#F5){ref-type="fig"}), which may contribute to the aforementioned missing S15 and Z1644 ORFS. The F2_18C PAI~*CL*3~ isoform is not present in any other ST302 ([Figure 4](#F4){ref-type="fig"}).

![F2_18C pathogenicity island comparisons. Mauve and Easyfig alignments and SnapGene annotations depicting **(A)** the ETT2 regions in *E. coli* strains Sakai and F2_18C (F2_18C sequence is depicted in a reversed orientation) and **(B)** the PAI~*CL*3~ regions in strains CL3 and F2_18C. The arrow colors represent% amino acid similarity: red = \> 95%, orange = \> 90%, yellow = \> 85%, green = \> 60%, purple = \> 45%, brown = \< 34%, white = ORF not present in CL3, black = ORF not present in F2_18C, checkered = pseudogenes, striped = ORF predicted in F2_18C.](fmicb-10-03098-g005){#F5}

As aEPEC can be converted to EHEC by the presence of *stx*-carrying bacteriophages, the F2_18C chromosome was also checked for potential *stx1* and *stx2* integration sites ([@B17]), and was found to have the following unoccupied: *wrbA* (2984895.2985491), *yehV* (1780350.1781081), *yecE* (2076464.2077282), *sbcB* (1921208.1922635), *Z2577* (2354785.2354802) and the *torS/torT* intergenic region (2996339.2996467). Additionally, F2_18C possesses the lambda phage receptor gene LamB (4667691.4669028) required for lambda bacteriophage adsorption ([@B14]). F2_18C also possesses the *argW* integration site (1521099.152173); however this site is occupied by a non-*stx-*carrying lambdoid prophage.

### F2_18C AMR Plasmid {#S3.SS4.SSS2}

Unicycler hybrid assemblies resolved plasmid pF2_18C_HI2 as a 274, 059 bp circular sequence with 343 CDSs (163 with functional assignments and 180 hypothetical proteins). It carries 17 IS elements, with IS*26* variant IS*15DI* being the most common (*n* = 8), followed by IS*903B* (*n* = 3). The plasmid was typed using pMLST as incompatibility group HI2, sequence type 3 (HI2:ST3). A full plasmid map is presented in [Figure 6A](#F6){ref-type="fig"}, along with content comparisons to high sequence identity (\>98%) matched HI2:ST3 plasmids publicly available (*n* = 33). pF2_18C_HI2 has three regions of AMR carriage. One region comprises a class 1 integron (*intI1*) located within a *Tn172/Tn21* hybrid tetracycline resistance (*tetA*, *tetR*) transposon that has acquired *dfrA12* (trimethoprim resistance) and *aadA2* (aminoglycoside resistance) cassettes with *qacE*Δ*1* (small multidrug resistance efflux transporter), and *sul1* (sulfonamide resistance) genes ([Figure 6Ci](#F6){ref-type="fig"}). A second region contains a truncated *sul3*-associated class 1 integron structure, located near a *Tn7*-like transposon mobilizing copper and silver (*sil*/*pco*) resistance genes at one end and a tellurium resistance genes (*ter*) at the other. The atypical *sul3*-associated integron encodes *estX* (aminoglycoside resistance), *psp* (phosphoserine phosphatase), *aadA2* (aminoglycoside resistance), *cmlA* (phenicol resistance) and *aadA1* (aminoglycoside resistance) cassettes. Further upstream lies a novel truncated version of macrolide resistance gene Δ*mefB*~150~, *sul3* (sulfonamide resistance) and *strA* and *strB* (aminoglycoside resistance) genes ([Figure 6Cii](#F6){ref-type="fig"}). The third region ([Figure 6Ciii](#F6){ref-type="fig"}) is flanked by direct IS*15DI* and contains *aph(3′)-IIa* (neomycin, kanamycin, paromomycin, butirosin, gentamicin B and ribostamycin resistance), bleomycin resistance gene *blemS*, and a NimC/NimA family gene (nitroimidazole reductase) as well as *relE*/*relB* toxin/antitoxin genes and three conjugation proteins, *traO, traF*, and *traG*. This third region appears unique to three other Australian isolates ([Figure 6A](#F6){ref-type="fig"}) and may represent a new IS*15DI*-mediated transposon that has evolved in Australia. However, these regions have undergone some inversions and rearrangements, and acquired probable IS1*5DI*-mediated fluoroquinolone resistance genes *oqxABR* in pSDC-F2_12BHI2 ([Figure 6D](#F6){ref-type="fig"}).

![Plasmid maps and BRIG comparison of HI2:ST3 plasmids. **(A)** Plasmid map of pF2_18C_HI2 and alignments of other HI2:ST3 plasmids. **(B)** Plasmid map and alignments of pMCR_WHEC050613 from *E. coli* strain WCHECO50613 isolated from sewerage in China. Plasmid maps show gene annotations and are color coded by function (legend top center). **(C)** Gene structures of F2_18C AMR regions, flagged in **(A)**. **(D)** Mauve alignment of region iii found in other HI2:ST3 isolates originating from Australia.](fmicb-10-03098-g006){#F6}

The three AMR regions account for most of the structural difference between pF2_18C_HI2 and other HI2:ST3 plasmids ([Figure 6A](#F6){ref-type="fig"}). However, HI2:ST3s carry a smorgasbord of diverse AMR genes ([Figures 6B](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). Currently, no HI2:ST3 plasmid originating from Australia carries any extended-spectrum beta lactams (ESBLs), colistin, fosfomycin or rifampicin resistance genes, unlike HI2:ST3 plasmids originating from Asia ([Figure 7](#F7){ref-type="fig"}).

![HI2:ST3 AMR gene carriage profiles. AMR genes present in the 33 HI2:ST3 plasmids analyzed in [Figure 6](#F6){ref-type="fig"}. Flags on the right represent isolation location and from top to bottom are Australia, Bangladesh, China, Hong Kong, and South Korea.](fmicb-10-03098-g007){#F7}

### F2_18C Virulence Plasmid {#S3.SS4.SSS3}

Unicycler hybrid assemblies resolved pF2_18C_FIB as a circular sequence of 82, 910 bp containing 100 CDSs (76 with functional assignments, and 24 encoding hypothetical proteins). pF2_18C_FIB contains 6 IS elements with IS*1203* (IS*629* variant) being the most common. This plasmid could not be typed by pMLST, however, it has \>99% sequence identity with four FIB13 plasmids, all of which associate with *E. coli* ST17 but of varying serotypes (O45:H2, O153:H2 and two O103:H2). The difficulties in typing may be attributed to an additional RepA replicon in pF2_18C_FIB, which is also seen in pO157 found in O157:H7 strains ([Figure 8](#F8){ref-type="fig"}). In terms of virulence, like the FIB13 plasmids, pF2_18C_FIB carries hemolysin encoding genes (*ehxA*, *hlyB*, *hlyC*, *hlyD*), lipid A modification/synthesis genes (including *msbB*), *stcE* (secreted protease of C1 esterase inhibitor from EHEC), and EHEC associated gene *etpD.* pF2_18C_FIB also carries the catalase gene *katP*, only seen in one other FIB13 plasmid; however, the F2_18C *katP* gene is more homologous to *katP* from pO157 ([Figure 8](#F8){ref-type="fig"}). These plasmids have undergone considerable inversions and rearrangements, which may be the result of the IS elements that flank most regions ([Figure 8](#F8){ref-type="fig"}). pF2_18C_FIB and the FIB13 plasmids share homology to EHEC plasmid pO157 (66% coverage at 90% identity); however, pO157 (from strain Sakai) is 12,688 bp larger than pF2_18C_FIB and contains additional virulence factors including the *toxB* gene and serine protease *etpP* ([Figure 8](#F8){ref-type="fig"}).

![pF2_18C_F plasmid map and FIB13 plasmid alignments. Plasmid maps showing gene annotations for pF2_18C_FIB and four FIB13 plasmids and one FIB23 plasmid over a mauve alignment to demonstrate homologous regions.](fmicb-10-03098-g008){#F8}

### F2_18C Col Plasmid {#S3.SS4.SSS4}

Three F2_18C contigs did not circularize; however, they have homology to *Shigella sonnei* ColRNAI plasmids ([Figure 9](#F9){ref-type="fig"}). Like the *S. sonnei* plasmids, F2_18C contig 4 carries colicin-10, the colicin transporter, colicin lysis protein, a partial replication initiation protein and two plasmid exclusion proteins, but additional carries a mobC family plasmid mobilization relaxome protein (100% amino acid sequence identity to *E. coli* mobC WP_00613379.1) and a nuclease (100% sequence identity to *E. coli* nuclease WP_00635769.1). Contig 5 carries the nickel ABC transporter protein NikA, common to the *S. sonnei* plasmids but has additional hypothetical proteins, and contig 6 consists of non-coding DNA common to the *S. sonnei* plasmids.

![F2_18C contig annotation with mauve alignments to ColRNAI plasmids. Three F2_18C contigs were aligned to ColRNAI_1 plasmids from *S. sonnei* strains (∼98% identity through PLSDB). Homologous regions are shown in color. Two gray boxes within the annotation denote repeat regions.](fmicb-10-03098-g009){#F9}

Discussion {#S4}
==========

aEPEC are emerging enteropathogens that have been detected in both humans and animals globally. However, aEPEC are a heterogenous pathotype regarding their serotypes, STs, virulence factors and ability to cause disease. *E. coli* ST302 strains are aEPEC that have been isolated from both healthy and diseased animal and human hosts, yet no study to date has focused on this ST. Here we present the first closed chromosome and two circularized plasmids (pMLST types HI2:ST3 and FIB) from an ST302 strain; F2_18C, isolated from a healthy pig from Australia. Additionally, we compare F2_18C virulence and AMR gene cargo with other *E. coli* ST302 strains from a range of hosts including a human isolate, using Illumina short-read gene screening and compare F2_18C plasmids to those with high sequence identity.

Enteric colibacillosis is a significant cause of economic losses to pig industries worldwide ([@B33]). The major causative pathotype is enterotoxigenic *E. coli* (ETEC), which is routinely screened for by veterinary diagnostic laboratories, and characterized by their fimbriae and enterotoxins ([@B33]). However, though not routinely screened for, aEPEC (*eae*+, *stx*−, *bfp*−) are also known to cause enteric colibacillosis in swine ([@B33]; [@B65]) and [@B40] found aEPEC outnumbered ETEC as the causative agents in suckling piglets. Nevertheless, *eae*+ *E. coli* has been isolated from both healthy and diarrheic pigs ([@B57]; [@B38]; [@B67]), implying that a combination of additional VAGs, as well as host-related factors, and poor herd management and husbandry practices, are required to establish disease.

Despite being isolated from a healthy pig, aEPEC strain F2_18C possesses almost twice as many VAGs than non-pathogenic *E. coli* strain MG1655 ([Figure 1](#F1){ref-type="fig"}). Many of these VAGs are carried on MGEs, including plasmids, prophage-like elements, and genomic islands. F2_18C carries an 82,910 bp plasmid, pF2_18C_FIB, with high sequence identity to FIB13 plasmids from EHEC ST17 strains ([Figure 8](#F8){ref-type="fig"}). These plasmids carry VAGs implicated in EHEC virulence, including the pore-forming toxin *ehxA*, T2SS gene *etpD*, C1 esterase inhibitor cleaving protease *stcE*, and lipid A synthesis gene *msbB* ([@B87]; [@B71]). Additionally, pF2_18C_FIB and one other ST17 plasmid carry the *katP* gene. *katP* encodes for a catalase-peroxidase thought to be expressed by pathogenic *E. coli* as a defensive mechanism against host-mounted oxidative stress ([@B93]). *katP* was also shown to be significantly associated with ST17 human isolates, rather than animal isolates ([@B86]), though in ST11s (O157:H7) *katP* has been found equally distributed among human and bovine isolates ([@B44]). Nevertheless, EHEC strains carrying both *katP and stcE* have been linked to high virulence ([@B56]). pF2_18C_FIB and the ST17 FIB13 plasmids share homology with pO157 found in the most notorious of food-borne pathogens O157:H7 ([Figure 8](#F8){ref-type="fig"}). However, they lack the adhesin *toxB* and the serine protease *espP*, which cleaves pepsin A and human coagulation factor V, hence thought to contribute to hemorrhagic colitis symptoms ([@B19]).

In addition to pF2_18C_FIB, F2_18C has three contigs that did not circularize, but nonetheless have high sequence identity to *S. sonnei* ColRNAI plasmids. These plasmids carry colicin-10, and the colicin-10 immunity gene, which are also present in F2_18C contig 4 ([Figure 9](#F9){ref-type="fig"}). Colicins are a type of bacteriocin produced by and active against *E. coli* ([@B37]). In the advent of plasmid-mediated colistin resistance, particularly in swine, colicins are currently being given consideration as viable alternatives to antibiotics ([@B12]). In particular, colicin E1 has been shown to inhibit the growth of swine ETEC strains *in vitro* ([@B41]), and the addition of colicin E1 to pig feeds has been shown to decrease the severity and incidence of ETEC infections ([@B27]). However, the colicin-10 immunity protein grants full protection against colicin E1 activity ([@B76]). Thus, a potential colistin-10 plasmid circulating amongst a pig population may dampen efforts in implementing colicin-E1 as an effective agent against ETEC and growing AMR in swine.

Like all aEPEC, F2_18C harbors a chromosomal LEE pathogenicity island that includes intimin (*eae*), an adhesin with a critical role in intestinal colonization. There are at least 30 distinct subtypes of intimin ([@B80]; [@B103]), and it is thought that specific subtypes may be involved in tissue tropism and host specificity ([@B46]; [@B90]). The ability of intimin to also bind β--integrins may be significant in this regard ([@B75]). The *eae* gene in F2_18C is subtype β1, which has been significantly correlated to disease in human patients ([@B103]), and is common in cattle and in healthy pigs ([@B80]; [@B57]; [@B68]; [@B38]). In addition to LEE, F2_18C carries two other pathogenicity islands, ETT2, and PAI~*CL*3~ ([Figure 5](#F5){ref-type="fig"}). ETT2 shares homology to the *Salmonella* type 3 secretion system located on the *Salmonella* pathogenicity island 1 (SPI-1). Though it is thought unlikely that ETT2 functions as a secretion system, it is known to influence virulence by regulating VAGs expression ([@B108]; [@B66]), promoting motility, adhesion, biofilm formation and serum survival ([@B108]; [@B84]), and enhancing invasion and intracellular survival ([@B104]). While most *E. coli* strains possess ETT2 gene clusters, the vast majority have undergone extensive deletions and mutations ([@B82]; [@B108]). However, intact ETT2s are prevalent in pathogenic porcine EHEC strains, particularly those associated with *stx~2*e*~* ([@B24]). F2_18C possesses the full complement of ETT2 genes ([Figure 5A](#F5){ref-type="fig"}), however an IS1F insertion interrupts the *eivG* gene, and *eivC* gene is truncated. The latter observation may be particularly important as *eivC* is involved in motility, serum resistance and intra-macrophage survival, at least in avian pathogenic *E. coli* (APEC) ([@B96]).

Like ETT2, PAI~*CL*3~ is rarely found in its entirety, and in most cases, all that remains are boundary genes ([@B42]). The complete PAI~*CL*3~ locus is a hybrid genomic region of 35 ORFs, composed in part, of a *Yersinia pestis*-like hemolysin/adhesin genes cluster, OI-122 genes, including the VAG *pagC*, and OI-48 genes ([@B42]). PAI~*CL*3~ was originally believed to be restricted to LEE-negative STEC only and a significant predictor of a virulent status ([@B42]). However, [@B10] identified PAI~*CL*3~ in 8 (11.3%) O26 EHEC and EPEC strains of human and bovine origins. These strains had the three left-side boundary OI-48 genes (Z1635-7), the hemolysin/adhesin cluster (S1--S4), and the three right boundary OI-48 genes (S15, Z1643-4), however most lacked S5--S14 genes (10 genes), including the five OI-122 genes. Conversely, the F2_18C PAI~*CL*3~ isoform remains near intact, lacking only two right-side boundary genes ([Figure 5B](#F5){ref-type="fig"}). To our knowledge, this is the first time PAI~*CL*3~ has been described in swine and has potentially negative implications for its use as a marker for highly virulent strains.

The F2_18C chromosome is infected with 13 prophage elements ([Figure 4](#F4){ref-type="fig"}), which carry a number of VAGs including non-LEE encoded effectors, iron acquisition genes and EHEC-associated gene Z2121 ([@B30]). The *aidA* gene was also found on a prophage element. This gene encodes for a membrane-bound autotransporter protein that functions as an adhesin that self-associates and also interacts with Ag43, another surface adhesin, to promote biofilm formation ([@B83]). An *aidA-*deletion mutant ETEC strain was shown to lose the ability to colonize and induce disease in swine emphasizing the important role it plays in pathogenesis ([@B33]). Importantly, *aidA* was one a several genes that resulted in a false-negative identification by short-read gene screening ([Table 1](#T1){ref-type="table"}). Bacteriophages are the most abundant life-form on earth ([@B20]) and are widespread in sewage effluent. Given the propensity of aEPEC to be converted to EHEC by the introduction of Shiga toxin*-*carrying lambdoid bacteriophages ([@B32]), F2_18C was checked for known *stx1* and *stx2*-phage integration sites and was found to have several vacant. It is theorized that aEPEC are the progenitors of EHEC ([@B58]; [@B32]), and so it is therefore prudent to monitor their VAG cargo, particularly EHEC-associated VAGs, and factor in aEPEC detection into EHEC control measures. That being said, though the virulence potential of F2_18C appears high, no STEC ST302 strains have been observed, and F2_18C was isolated from a healthy pig, therefore it was also prudent to take note of EPEC/EHEC VAGs missing in this strain ([Table 2](#T2){ref-type="table"}). Nonetheless, serotype O108:H9 *E. coli* such as F2_18C are frequently isolated from pigs with gastrointestinal disease ([@B68]; [@B55]) and from healthy swine ([@B57]; [@B38]) suggesting that they may be opportunistic pathogens that cause diarrheal disease in swine during stressful episodes such as weaning.

When compared to other *E. coli* ST302 strains, F2_18C had more VAGs than most, with the notable exception of two O182:H9 strains 29563 and 29396. These two strains were highly homologous in their VAG profile ([Figure 3](#F3){ref-type="fig"}) and were the only two in addition to F2_18C to carry the EHEC plasmid marker genes *ehxA, etpD*, and *katP.* However, unlike F2_18C, 29563 and 29396 appear to have acquired several extraintestinal *E. coli* (ExPEC) VAGs, including *cvaA, iha, shiD* and genes encoding aerobactin iron acquisition. Additionally, 29563 and 29396 uniquely carry *nleB1, nleE* and *espL2/ent*, which together with *eae*, represent a strong signature for human pathogenic EHEC ([@B21]). Incidentally, both maximum-likelihood and SNP-based phylogenetic analyses ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}), place F2_18C, 29563 and 29396 in a distinct off-shoot from other *E. coli* ST302 strains and may represent an evolutionary pathway shaped by VAG acquisition. When compared to 76 *E. coli* genomes of varying STs, serotypes, phylogroups and hosts, *E. coli* ST302 strains were most closely related to EHEC O145:H28 strains, two of which, RM12581 and RM12761, were associated with major food-borne outbreaks ([@B26]) ([Figure 2](#F2){ref-type="fig"}).

As well as being an ST302 with one of the highest virulence potentials, F2_18C also carries the most AMR genes acquired through HGT ([Figure 3](#F3){ref-type="fig"}). This is, in all likelihood, due to F2_18C being only one of two ST302 strains to carry an intact class 1 integron marker gene *intI1.* Integrons are MGEs capable of capturing and mobilizing functional gene cassettes, and class 1 integrons have played a pivotal role in disseminating antibiotic resistance worldwide ([@B45]). F2_18C carries ARGs conferring resistance to aminoglycoside (*aadA1, aadA2*), chloramphenicol (*cmlA*), kanamycin and neomycin \[*aph(3′)-IIa*\], streptomycin (*strA, strB*), sulphonoamide (*sul1, sul3*), tetracycline (*tetA, tetR*) and trimethoprim (*drfA12*). Strain 267792, the only other ST302 to carry an intact *intI1* gene, was isolated from a human in the United Kingdom, and possesses a different AMR profile to F2_18C, carrying additional genes conferring resistance to macrolides (*mphA*) and quinolone (*qnrB19*), but lacking resistance genes to chloramphenicol, streptomycin, kanamycin and neomycin. Limitations of our ST302 VAG and ARG comparisons include the reliance of short-read data, which we previously mentioned can provide false-negatives, the limited number of ST302 genomes currently available and the limited metadata provided for strains, including the host, isolation date and location for some strains, and host disease status for all strains, except F2_18C. We were able to map all F2_18C horizontally transferred ARGs to a 274, 059 bp circular plasmid, pF2_18C_HI2 ([Figure 6A](#F6){ref-type="fig"}). This plasmid was typed by pMLST as HI2:ST3, a lineage known as a major contributor in transferring complex class 1 integrons conferring AMR ([@B106]) pF2_18C_HI2 is very similar to three HI2:ST3 plasmids circulating in Australian pig farms ([@B31]; [@B16]; [@B102]) ([Figure 6A](#F6){ref-type="fig"}). pF2_18C_H12 carries the same AMR profile as pSDE-SvHI2, isolated from a severe ETEC strain ([@B102]), and differs to a pSDC-F2_12BHI2, isolated from a commensal *E. coli* strain ([@B102]), and pSTM6-275, isolated from *Salmonella enterica* subsp. *Enterica* Typhimurium ([@B31]), by lacking aminoglycoside resistance gene *aph(3′)-Ia* and fluoroquinolone resistance genes *oqxAB* in the former, and beta-lactam resistance gene *blaTEM-1B* in the latter.

We compared the AMR cargo of 34 HI2:ST3 plasmids ([Figure 7](#F7){ref-type="fig"}), five from Australia, one from an unspecified origin, and 28 from Asia, the vast majority of which originated in China. Perhaps due to restrictions on live animal imports and stringent antibiotic usage practices, HI2:ST3 originating from Australia do not, yet, carry any ARG conferring resistance to extended spectrum beta-lactams (ESBLs), colistin, fosfomycin or rifampicin. This is in stark contrast to HI2:ST3 plasmids originating from Asia, in which ESBL genes, such as *bla~*CTX--M--*14,--55,--65,--199~, bla~*OXA--*1,\ --10~*, and fosfomycin gene *fosA3*, are prevalent. Moreover, 54% of HI2:ST3s from China carry colistin-resistance gene *mcr-1*. The increased global usage of colistin in agriculture coincided with the rising prevalence of multidrug resistant Enterobacteriaceae ([@B34]). China, being the world's largest producer of pork, is incidentally also the world's largest user and producer of colistin, making up to 73% of global colistin production and driving global demands for agricultural colistin usage to an anticipated 11,942 tons per annum in 2015 ([@B63]). Resistance to colistin was originally believed to only occur from relatively rare mutations in a lipid A modification gene ([@B35]). Although, the first plasmid mediated-colistin resistance was identified in swine from China in 2015 ([@B63]), it has now been identified in over 31 countries across five continents from a range of animal and human hosts, sparking worldwide concern, as colistin is used clinically as a last resort for multidrug resistant Gram-negative infections ([@B47]). The colistin resistance gene *mcr-1* is mobilized by the transposon Tn*6330* (IS*Apl*1-*mcr-1*-orf-IS*Apl*1) which can generate a circular intermediate (Is*Apl*1-*mcr-1*-orf) ([@B61]; [@B95]). This circular intermediate is capable of inserting itself into the highly conserved HI2:ST3 backbone ([Figure 6B](#F6){ref-type="fig"}). China banned the use of colistin in pig feeds in 2016 ([@B94]), however, due to the sheer number of ARG carried by these plasmids, as well as large metal-resistance regions ([Figure 6](#F6){ref-type="fig"}), researchers fear that selective-pressures, through the use of other antibiotics and metal feed additives, will still favor these plasmids, and colistin resistance will continue to spread.

Conclusion {#S5}
==========

Despite the limited number of publicly available genome sequences it is evident that ST302 *E. coli* should be broadly considered aEPEC strains that may reside in healthy hosts or cause opportunistic disease. Of concern is the apparent divergence of strains encoding additional virulence traits including those typical of EHEC and ExPEC, which may yield more severe disease presentation. It would be of great benefit to phenotypically characterize these strains in order to fully understand their potential for pathogenicity in humans and animals. Furthermore, the acquisition of MDR plasmids in lineages with pathogenic potential is a major issue for global public health as antimicrobial use may co-select for virulence traits. Our study highlights *E. coli* ST302 as a potentially emerging pathogen that should be monitored in the context of public health. However, further genomic epidemiology studies of *E. coli* ST302 within a One Health framework are required to fully understand this lineage, its virulence potential, and inform genomic surveillance in the future.
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